29^th International Conference on Cardiology and Healthcare June 10-11, 2019 Scandic Jarvenpaa | Helsinki, Finland

He has authored/edited many textbooks and monographs in the field of clinical genetics, cardiovascular genetics and genomic medicine & healthcare. He is passionate for raising awareness and promoting importance of inherited cardiovascular conditions (ICC) in clinical cardiology and genetic medicine. He is acknowledged with the benchmark practice of ‘multi-disciplinary care for inherited/familial heart diseases’. He founded and leads the ‘Global Familial Heart Challenge’ project for identification and detection of preventable familial heart diseases globally. He is one of the founding members of the Association for Inherited Cardiac Conditions (AICC) and serves on the British Heart Foundation led national steering group for ICC.

Cardiovascular genetics, genomic medicine and genomic applications in global healthcare.

Marco Picichè (MD, Ph.D.) graduated with a degree in medicine from the University of Florence in 1995 and completed his cardiac surgery residency at the Tor Vergata University of Rome in 2000, both summa cum laude. He held regular teaching appointments at the university of Montpellier school of medicine, obtained certification by the French Board in cardiac surgery (Paris, 2007), earned his research master in surgical science (Paris, 2007), and received a university diploma in vascular surgery (Paris, 2007). In Canada he authored a research project on the occlusion of the internal mammary arteries as an alternative method of myocardial blood supply (2008, Laval University). In May 2009 he had the honor of opening the 44th Congress of the European Society for Surgical Research with a lecture on ‘‘The history of surgical research.’’ In September 2011 he received a doctor of philosophy (Ph.D.) in therapeutic innovations from Paris-Sud University. He is the Editor in Chief of the book : « Dawn and evolution of cardiac procedures : research avenues in cardiac surgery and interventional cardiology » (Springer-Verlag publishing house, September 2012). He patented a new surgical instrument. Currently he is a cardiac surgeon in Italy.

Cardiac surgery, Interventional cardiology

Dr. Maria Dorobantu has worked as senior specialist in internal medicine and Senior specialist in cardiology during 1990-1996. She is Director of the Research Center of Excellency for the diagnosis and treatment of cardiovascular emergencies and she is Director of Hypertension Center of Excellence, European Society of Hypertension. She is Initiator and Coordinator for National Studys SEPHAR (I-III). She is reviewer for multiple journals viz., American Heart Journal, Cor et Vasa, Journal of Hypertension, PLOS ONE

Arterial Hypertension, Acute Coronary Syndrome, Heart Failure

Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, main-tained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences, Moscow, Russia. In 2001, finished the PostDoc Research Fellowship Program and maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1985 through 1987, worked at Inst of Med Enzymology, USSR Academy of Medical Sciences. From 1987 through 1989, was a senior Researcher, Koltzov Inst of Developmental Biology, USSR Academy of Sciences. From 1989 through 1995, was being a Head of the Lab of Clinical Immunology and Immunobiotechnology, Helmholtz Eye Research Inst in Moscow. From 1995 through 2004, was being a Chairman of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI) and the Immunologist-in-Chief of the Moscow Regional Ministry of Health. In 1993-1996, was an Executice Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. Dr Suchkov is a Co-Supervisor over the Russian-American Agreement on scientific and clinical collab-oration in the field of ocular immunology between Russian Academy of Sciences and National Insti-tutes of Health (NIH); in 1991-1995 – a member of The Reciprocal Exchange Fellowship Program between Russian Immunological Society and British Society for Immunology. Dr Suchkov is a member of the Editorial Boards of many international journals including EPMA Jounal (Springer, Brussels) and “Personalized Medicine Universe” (Elsevier, Japan). Dr Sergey Suchkov, MD, PhD Director, Center for Personalized Medicine and Professor, Department of Pathology, Sechenov University, Chair, Department for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), Professor, Dept for Immunology, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Moscow, Russia Member, New York Academy of Sciences, NY, USA, Secretary General, UCC (United Cultural Convention), Cambridge, UK Member, EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brus-sels, EU; Member, ISPM (International Society for Personalized Medicine), Tokyo, Japan; Member, PMC (Personalized Medicine Coalition), Washington, USA; Member, American Chemical Society (ACS), USA; Member, American Heart Association (AHA), USA; Secretary General, UCC (United Cultural Convention), Cambridge, UK

Immunochemical characteristics of three novel reina-specific antigens in humans and some mammals, Serology in ophthalmic oncology - findings and outlook for the future, Catalytic antibodies in immune-mediated disor-ders, Clinical and immune-mediated syndrome (CAIMS) in clinical practice: features and strate-gies in immune and molecular diagnostics

Dr. Ellahham is Regional Chair, Middle East, Patient Safety Movement Foundation Middle East Representative of the JCI Standards Subcommittee. Dr. Ellahham has served, in past, as Chief Quality Officer for SKMC since 2009. In his role, Dr. Ellahham has led the development of a quality and safety program that has been highly successful and visible and has been recognized internationally by a number of awards. As Chief Quality Officer and Global Healthcare Leader, Dr. Ellahham has a focus on ensuring that that implementation of this best practices leads to breakthrough improvements in clinical quality, patient safety, patient experience and risk management. Dr. Ellahham is a recognized innovative leader in quality, safety, patient experience, risk management and the use of robust performance improvement in improving healthcare delivery. He serves on a number of US and international committees and advisory bodies. He is the Middle East Regional Chair of the Patient Safety Movement Foundation. Dr. Ellahham is Certified Professional in Healthcare Quality (CPHQ) by The National Association for Healthcare Quality (NAHQ). He is certified in Medical Quality (CMQ) by The American Board of Medical Quality (ABMQ). He is the recipient of the Quality Leadership Award from the World Quality Congress and Awards and the Business Leadership Excellence Award from World Leadership Congress in 2015. He is one the nominees for Safe Care magazine Person of the Year in the United States. Dr. Ellahham is the recipient of prestigious SKMC Infection Prevention Award in 2011 and 2012. He is recognized worldwide for Excellence in infection prevention and control. Dr. Ellahham is Middle East Representative of the JCI Standards Subcommittee and Member on the Editorial Advisory Board of the Joint Commission Journal on Quality and Patient Safety. He is reviewer of HCAC Cardiac Quality and Safety Standards. Dr. Ellahham has been a champion of the use of Lean, Six Sigma and Change Management to improve healthcare quality. He is Lean Six Sigma Master Black Belt Certified. He is an American Society of Quality (ASQ) trainer in lean and six sigma both green and black belt. He was the Leader of the First Pilot International Robust Process Improvement (RPI) project by the Joint Commission Center for Transforming Healthcare and several other similar successful performance improvement projects at SKMC. He is Lead Trainer in TeamSTEPPS Lead Trainer. Dr. Ellahham is certified as EFQM 2013 Model assessor and is leading EFQM Excellence Model at SKMC with great success including winning the prestigious Sheikh Khalifa Excellence Award in 2014, Dubai Quality Award in 2015 and Sheikh Khalifa Excellence Golden Award in 2015. Dr. Ellahham is the Executive SKMC sponsor of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) the leading US validated, risk-adjusted, outcomes-based program to measure and improve the quality of surgical care. SKMC is the first multispecialty ACS NSQIP center outside the US. Dr. Ellahham led the publication of, first in the region, annual SKMC outcome books since 2011. He is a strong believer in transparency in health care and external reporting. Dr. Ellahham is a Board-certified internist, cardiologist and vascular medicine senior consultant and continues to care for patients. He received his undergraduate degree in biology and his M.D. from the American University of Beirut, Beirut, Lebanon. Dr. Ellahham did his fellowship in Cardiology at the Medical College of Virginia (MCV) in USA. After completing his fellowship, Dr. Ellahham worked in Washington DC in several clinical and leadership positions before moving to UAE in 2008. He led the First AHA GWTG Heart Failure Initiative outside US and was the recipient of the AHA GWTG Award in Wash. DC. He is the champion of the AHA GWTG in the region. Dr. Ellahham continues to be an active clinician. He is board certified in internal medicine, vascular medicine, cardiology and quality. He was recently recertified in 2017 by the American Board of Cardiology (ABIM). He demonstrated great skill and experience in the management of patients with heart failure, ischemic heart disease, and valvular heart disease and led a multi-disciplinary team in the care and delivery of advanced therapies to these patients. He has unique abilities to partner and engage local and regional referring providers. He is able to work in a highly matrixed environment, possess strong leadership and organizational skills and have experience to working effectively in a large health system. He is a fellow of the American College of Cardiology and key member in Heart Failure and Transplant, Adult Congenital and Pediatric Cardiology, Cardio-oncology and Peripheral Vascular Disease Sections. He is currently Cleveland Clinic Staff and on the Executive Team of The Cleveland Clinic Foundation, in Abu Dhabi, UAE. Dr. Ellahham is a fellow of the American College of Cardiology, American College of Chest Physicians, American College of Physicians, and American Heart Association. Dr. Ellahham is a Distinguished Fellow of the New Westminster College in British Columbia, Canada. Dr. Ellahham is an avid researcher; his research includes innovation, digital healthcare solutions, telemedicine, block chain, patient experience and engagement, lean six sigma, change management, innovation, safety, risk management, KPI management, safe surgery, heart failure, molecular biology, genetics, cardiac imaging, sports and nutrition. He is a recognized world-leader in these fields.

Heart failure, Ischemic Heart Disease, and Valvular Heart Disease

Nandkishore Kapadia has completed his MBBS, MS from Indore University, MCh from Madras University, and PhD from VGU British I land, postdoctoral studies from Allegheny University School of Medicine Philadelphia USA. He has published more than 20 papers in reputed journals. He is head of Department of Adult Cardiac Surgery and Director of Heart & Lung Transplant Program at Prestigious Kokilaben Dhirubhai Ambani Hospital Mumbai India. He is member of ZTCC, ROTTO dealing with Human Organ and Tissue Transplantation. He is founder president of mission save heart Foundation working to improve health services in India and Africa.

Adult Cardiac Surgery, Heart & Lung Transplantation